CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 32.62% | — | — | |
| 2 | IFRX | InflaRx N.V. | Stock-Other | 21.93% | — | — | |
| 3 | SLDB | Solid Biosciences Inc. | Stock-Other | 18.22% | — | — | |
| 4 | ✓ | Aptinyx INC | Stock-Other | 12.58% | — | — | |
| 5 | REPL | Replimune Group INC | Stock-Other | 9.70% | — | — | |
| 6 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 4.95% | — | +26.78% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IFRX | InflaRx N.V. | +8.2% | — | Unchanged |
| 2 | DRNAUSD | Dicerna Pharmaceuticals INC | +1.7% | — | Unchanged |
| 3 | REPL | Replimune Group INC | -0.7% | — | Unchanged |
| 4 | ✓ | Aptinyx INC | -2% | — | Unchanged |
| 5 | SLDB | Solid Biosciences Inc. | -3.1% | — | Unchanged |
| 6 | MRNSUSD | Marinus Pharmaceuticals INC | -4.1% | +26.78% | Add |